List of Excipients in API aflibercept
✉ Email this page to a colleague
Detailed excipient profiles for aflibercept
Excipient focus: ARGININE HYDROCHLORIDE
aflibercept drug variants containing ARGININE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing ARGININE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE
aflibercept drug variants containing HISTIDINE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing HISTIDINE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
aflibercept drug variants containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
aflibercept drug variants containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
aflibercept drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
aflibercept drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE
aflibercept drug variants containing SODIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing SODIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
aflibercept drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TREHALOSE DIHYDRATE
aflibercept drug variants containing TREHALOSE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Amgen Inc | aflibercept-ayyh | 55513-056 |
>Company | >Ingredient | >NDC |
aflibercept drug variants not containing TREHALOSE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Regeneron Pharmaceuticals Inc | aflibercept | 61755-005 |
Regeneron Pharmaceuticals Inc | aflibercept | 61755-050 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.